We didn't find a code matching
It is a strategic failure worth $15 billion in pre-generic revenue
As of December 2025, GLP-1 RA prescriptions account for more than 7% of all prescriptions
Neurology 41:5052 Cheng FC, Kuo JS, Chia LG, Dryhurst G (1996) Elevated 5-S-cysteinyldopamine/homovanillic acid ratio and reduced homovanillic acid in cerebrospinal fluid: possible markers for and potential insights into the pathoetiology of Parkinsons disease
Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy
( B and C ) Blood glucose levels ( B ) and plasma concentrations of ghrelin ( C ) measured in overnight-fasted db/db mice